BIB. M. Ismagambetov

B. M. Ismagambetov

*This is an algorithmically generated author record based on publicly available information.

B. M. Ismagambetov has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    COMPARATIVE STUDY OF ELISA STOP SOLUTIONS BASED ON MINERAL ACIDS

    by B.M. Ismagambetov, S.E. Shomanova, I.A. Akhazhanova, N.B. Esimbekova, Z.D. Ershebulov

    A comparative study of ELISA stop solutions prepared on the basis of hydrochloric, orthophosphoric and sulfuric acids was performed using a competitive ELISA model for detection of antibodies against bluetongue virus. It was demonstrated that the chemical nature and concentration of the acid significantly affect the optical density of negative (K-) and positive (K+) controls, the time-dependent change of the signal, and the ratio between negative and positive controls. Hydrochloric acid solutions within the range of 0.5-4.0 M provided a high initial signal for K- (approximately 2.0 OD units), limited optical density variation over 30 minutes (3-8%), and the highest control ratio values (50-90). Orthophosphoric acid resulted in an increase of the positive control signal over time, whereas sulfuric acid caused a decrease in both K- and K+ signals, leading to narrowing of the dynamic range. The findings confirm that the selection of the stop solution is a critical factor in ELISA standardization and directly influences the analytical reliability of the diagnostic test system.

  • Open Access

    SCALING COWPOX VACCINE PRODUCTION TECHNOLOGY: FROM DEVELOPMENT TO GMP STANDARDS

    by Назым Есимбекова, Жугунисов К.д., Кайсенов Д.н., Кожамкулов Е.м., Исмагамбетов Б.м., Абдураимов Е.о., Рсалиев А.с. А.с., Сихаева Н.с. Н.с., Ершебулов З.д.

    This paper presents a comprehensive analysis and systematization of the key stages of scaling the technological chain of production of cowpox vaccine, with an emphasis on the full-scale adaptation of production processes to strict criteria of good manufacturing practice (GMP). Special attention is paid to the detailed validation of all key stages, including virus cultivation, vaccine formation, lyophilization process and comprehensive quality control of the final product. Validation of key processes was carried out with careful elaboration of virus culture protocols, which included the use of the Nunc Cell Factory, ensuring high stability and reproducibility of the procedure. The introduction of improved methods of microbiological purity control at all stages of production, including regular checks for the presence of microorganisms and monitoring of environmental parameters, contributed to improving the reliability of the production process. Operational standardization was achieved through the integration of real-time systems for data monitoring and analysis, which helped minimize human error and improve production accuracy. As a result, key optimization strategies have been identified and implemented to improve production efficiency, including improving automation processes and digitalizing production lines. The results of the study represent a significant step forward in the development of veterinary vaccinology, providing a reliable basis for future developments and innovations in the field of prevention and treatment of infectious diseases in farm animals. The work highlights the importance of an interdisciplinary approach combining biological, engineering, and management competencies to achieve high standards of vaccine quality and safety. In light of the emerging challenges associated with changes in legislation and the development of new technologies, this work offers a platform for continuing research in the field of biotechnology and vaccine production aimed at adapting to the dynamic conditions of the veterinary industry.

  • Open Access

    FOOT-AND-MOUTH: ETIOLOGY, PATHOGENESIS, PREVENTION AND CONTROL MEASURES

    by N. B. Yessimbekova, B. M. Ismagambetov, Z. E. Yershebulov, З. Д. Ершебулов

    The last outbreak of foot-and-mouth disease in the Republic of Kazakhstan was detected in the East Kazakhstan region in 2013. As part of the approved FMD control strategy, the country's territory is divided into 2 free FMD zones (with and without vaccination).Specialists of the International Epizootic Bureau were invited to the republic, and the vaccines used were analyzed. And we must admit that this work has yielded certain results. Nine regions have been granted FMD-free status without vaccination. However, for the first time in many years, in January 2022, an outbreak of foot-and-mouth disease, a dangerous viral disease that can be transmitted to humans, was detected in the Karaganda region. Which crossed out almost all the work done on the way to well-being and zeroed out the chances for the development of export animal husbandry.Foot–and-mouth disease is a cross-border disease, the source of which is domestic and wild ungulates. This disease is caused by a virus of the genus Aphthovirus of the Picornaviridae family, which affects artiodactyls, both wild and domestic. Transmission of FMD virus from sick animals to other susceptible animals can occur directly or indirectly. Treatment and control of foot-andmouth disease among livestock or animals can be carried out through isolation and quarantine of sick animals, vaccination programs, biosafety measures in animal husbandry, monitoring of livestock movement and surveillance.